切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (05) : 304 -308. doi: 10.3877/cma.j.issn.1674-3253.2019.05.005

所属专题: 专题评论 文献

临床研究

S.T.O.N.E.评分系统对经皮肾镜疗效的预测价值
Bakhtiyor Sadykov1, 哈木拉提·吐送2, 瓦热斯·先木西丁2, 马军2, 阿斯木江·阿不拉2, 乃比江·毛拉库尔班2, 王玉杰2,()   
  1. 1. 830011 乌鲁木齐,新疆医科大学国际教育学院
    2. 新疆医科大学第一附属医院泌尿外科
  • 收稿日期:2018-10-11 出版日期:2019-10-01
  • 通信作者: 王玉杰

Preoperative evaluation value of S.T.O.N.E nephrolithometry scoring system for percutaneous nepherolithomy

Bakhtiyor Sadykov1, Tusong Hamulati2, Xianmuxiding Waresi2, Jun Ma2, Abula Asimujiang2, Maola Naibijiang2, Yujie Wang2,()   

  1. 1. International Education College of Xinjiang Medical Univerisity, Urumqi 830011, China
    2. Department of Urology, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, China
  • Received:2018-10-11 Published:2019-10-01
  • Corresponding author: Yujie Wang
  • About author:
    Corresponding: Wang Yujie, Email:
引用本文:

Bakhtiyor Sadykov, 哈木拉提·吐送, 瓦热斯·先木西丁, 马军, 阿斯木江·阿不拉, 乃比江·毛拉库尔班, 王玉杰. S.T.O.N.E.评分系统对经皮肾镜疗效的预测价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(05): 304-308.

Bakhtiyor Sadykov, Tusong Hamulati, Xianmuxiding Waresi, Jun Ma, Abula Asimujiang, Maola Naibijiang, Yujie Wang. Preoperative evaluation value of S.T.O.N.E nephrolithometry scoring system for percutaneous nepherolithomy[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2019, 13(05): 304-308.

目的

探讨S.T.O.N.E.肾结石评分系统预测经皮肾镜碎石取石术(PCNL)后结石清除率和术后并发症之间的关系,评价其预测PCNL治疗效果的价值。

方法

选取从2017年7月至2017年12月在我院施行PCNL的120例肾结石患者临床资料,通过分析患者一般情况、结石特征、手术情况及围手术期情况等,利用术前泌尿系CT平扫资料给S.T.O.N.E.评分系统的各指标进行测量并根据测量结果对患者进行评分,分析患者评分情况与结石清除率、术后并发症、手术时间,估计失血量,住院天数之间的关系。

结果

120例肾结石患者的结石清除率为85.5%(102/120),并发症发生率为6.7%(8/120),平均S.T.O.N.E.评分为(7.6±1.1)分。结石清除组的S.T.O.N.E.评分为(7.5±1.1)分,结石残留组的S.T.O.N.E.评分为(8.3±1.1)分,两组患者S.T.O.N.E.评分之间的差异有统计学意义(Z=-2.426,P=0.015)。S.T.O.N.E.评分与结石清除率(OR=2.740,P<0.01),手术时间(r=0.419,P<0.01)有相关性,但与术后并发症(OR=1.233,P>0.05),估计失血量(r=0.100,P>0.05),总住院天数(r=0.065,P>0.05)及术后住院天数(r=0.050,P>0.05)均不相关。

结论

S.T.O.N.E.评分越高PCNL术后结石清除率越低,手术时间越长,其与术后并发症的发生率,术中估计失血量,总住院天数及术后平均住院天数无相关性。

Objective

To investigate the relationship between S.T.O.N.E. nephrolithometry scoring system with stone clearance rate and postoperative complications, and to evaluate its ability to predict postoperative stone clearance rate and complications after percutaneous nephrolithotomy (PCNL).

Methods

The clinical data of 120 patients with renal calculus who underwent PCNL from July 2017 to December 2017 in our hospital were selected. The patient's general condition, stone characteristics, operation status and perioperative parameters were analyzed. Each patient was scored according to S.T.O.N.E nephrolithometry scoring system,the relationship between patient scores and stone clearance rate, postoperative complications, estimated blood loss, and postoperative hospital stay were analyzed.

Results

The overall stone clearance rate was 85.5% (102/120), the complication rate was 6.7% (8/120), and the average S.T.O.N.E. score was (7.6±1.1). The mean S.T.O.N.E. score of the stone free group and the stone residual group was (7.5±1.1) and (8.3±1.1), respectively. The difference between the S.T.O.N.E. scores of the two groups was statistically significant (Z=-2.426,P=0.015). The stone score were correlated with stone clearance rate(OR=2.740,P<0.05) and with operative time(r=0.419,P<0.05), but not correlated with postoperative complications(r=0.050,P>0.05), estimated blood loss(r=0.100,P>0.05), total hospital stay(r=0.065,P>0.05) and postoperative hospital stay(r=0.050,P>0.05).

Conclusions

The stone clearance rate after PCNL is correlated with S.T.O.N.E. score, however, there was no significant correlation between S.T.O.N.E. score with the incidence of postoperative complications.

表1 结石清除组与结石残留组患者临床资料的比较
项目 结石清除组(n=102) 结石残留组(n=18) 统计值 P值
年龄(岁) 44.4±1.4 45.6±3.0. t=-0.3201 <0.745
性别[例(%)] ? ? χ2=0.394 <0.530
? 70(68.6) 11(61.1) ? ?
? 32(31.4) 7(38.8) ? ?
体质量指数(kg/m2±s 25.6±3.3 25.1±3.8 t=0.535 <0.593
ASA分级[例(%)] ? ? χ2=0.789 <0.583
? Ⅰ级 27(26.5) 4(22.2) ? ?
? Ⅱ级 66(64.7) 11(61.1) ? ?
? Ⅲ级 9(8.8) 3(16.7) ? ?
患肾侧别[例(%)] ? ? χ2=4.135 <0.042
? 左侧 53(52) 14(77.8) ? ?
? 右侧 49(48) 4(22.2) ? ?
最大截面积(mm2±s 267±180 475±242 t=-4.269 <0.001
皮肾通道距离(mm,±s 98±20 80±17 t=3.484 <0.001
梗阻程度[例(%)] ? ? χ2=0.032 <0.856
? 无、轻度积水 59(57.8) 10(51.6) ? ?
? 中、重度积水 43(42.2) 8(44.4) ? ?
受累肾盏数(个,±s 1.6±0.8 3.3±0.6 t=-8.838 <0.001
结石CT值(Hu,±s 1 019±257 1 010±273 t=0.1298 <0.897
通道宽度[例(%)] ? ? χ2=14.88 <0.002
? 16 F 86(84.31) 10(55.6) ? ?
? 18 F 4(3.92) 0(0) ? ?
? 20 F 2(1.96) 0(0) ? ?
? 24 F 10(9.81) 8(44.4) ? ?
目标肾盏[例(%)] ? ? χ2=1.214 <0.545
? 2(1.96) 1(5.56) ? ?
? 89(87.26) 16(88.88) ? ?
? 11(10.78) 1(5.56) ? ?
失血量(ml,±s 63±15 79±43 t=-3.035 <0.003
总住院天数(d,±s 11±4 13±5 t=-2.016 <0.046
术后住院天数(d,±s 4.5±1.8 0.6±3.6 t=-2.714 <0.007
手术时间(min,±s 67±28 92±25 t=-3.475 <0.001
表2 结石清除组与残留组间S.T.O.N.E.评分各项分值比较[例(%)]
表3 S.T.O.N.E.评分系统及结石各项特征与结石清除状态的关系
表4 S.T.O.N.E.评分系统及结石各项特征与术后并发症的关系
[1]
Türk C, Petřík A, Sarica K, et al. EAU Guidelines on interventional treatment for urolithiasis[J]. Eur Urol, 2016, 69(3): 475-482.
[2]
王少刚,余虓,经皮肾镜碎石取石术的现状与进展[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2016, 10(3): 1-4.
[3]
Okhunov Z, Lesser M, Friedlander J, et al. Nephrolithometry: a novel surgical classification system for renal stones[J]. J Urol, 2013, 81(6): 1154-1160.
[4]
Elkoushy MA, Metwally AH, Noureldin YA. Implications of different nephrolithometry scoring systems on clinical practice of endourologists: An international web-based survey[J]. Arab J Urol, 2016, 14(3): 216-222.
[5]
Okhunov Z, Moreira D, George A, et al. PD32-09 multicenter validation of S.T.O.N.E. nephrolithometry[J]. J Urol, 2014, 191(4), e839.
[6]
Noureldin YA, Elkoushy MA, Andonian S. External validation of the S.T.O.N.E. nephrolithometry scoring system[J]. Can Urol Assoc J, 2015, 9(5-6): 190.
[7]
陈星,郭剑明,徐志兵, 等. S.T.O.N.E.肾结石评分系统用于经皮肾镜取石术的临床研究[J]. 中华泌尿外科杂志, 2014, 35(1): 40-44.
[8]
谭媛,石翊飒, 经尿道前列腺电切术中出血量测定方法的研究进展[J]. 国际麻醉学与复苏杂志, 2015, 36(3): 243-246.
[9]
Clavien PA, Barkun J, Oliveira MLD, et al. The Clavien-Dindo classification of surgical complications: five-year experience[J]. Ann Surg, 2009, 250(2): 187-196.
[10]
Thomas K, Smith NC, Hegarty N, et al. The Guy's stone score—grading the complexity of percutaneous nephrolithotomy procedures[J]. Urology, 2011, 78(2): 277-281.
[11]
Smith A, Averch TD, Shahrour K, et al. A Nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy.[J]. J Urol, 2013, 190(1): 149-156.
[12]
Chang WJ, Jung JW, Cha WH, et al. Seoul national university renal stone complexity Score for predicting stone-free rate after percutaneous nephrolithotomy[J]. PlosOne, 2013, 8(6): 1-8.
[13]
彭国辉,李汉忠,张玉石, 等. SHA.LIN评分系统的建立及其在预测经皮肾镜取石术结石清除率中的价值[J]. 中华泌尿外科杂志, 2015, 36(10): 746-751.
[14]
Mandal S, Goel A, Kathpalia R, et al. Prospective evaluation of complications using the modified Clavien grading system, and of success rates of percutaneous nephrolithotomy using Guy's Stone Score: A single-center experience[J]. Indian J Urol, 2013, 28(4): 392-398.
[15]
Vicentini FC, Marchini GS, Mazzucchi E. Utility of the Guy's stone score based on computed tomographic scan findings for predicting percutaneous nephrolithotomy outcomes.[J]. Urology, 2014, 83(6): 1248-1253.
[16]
Sinha RK, Mukherjee S, Jindal T, et al. Evaluation of stone-free rate using Guy's stone score and assessment of complications using modified Clavien grading system for percutaneous nephro-lithotomy[J]. Urolithiasis, 2015, 43(4): 1-5.
[17]
胡卫国,李建兴,杨波, 等. 改良Guy's肾结石分级法在预测经皮肾镜取石术后清石率中的应用研究[J]. 中华泌尿外科志, 2012, 33(10): 771-773.
[18]
Labadie K, Okhunov Z, Akhavein A, et al. Evaluation and comparison of urolithiasis scoring systems used in percutaneous kidney stone surgery[J]. J Urol, 2015, 193(1): 154-159.
[19]
Bozkurt I H, Aydogdu O, Yonguc T, et al. Comparison of Guy and clinical research office of the endourological society nephrolithometry scoring systems for predicting stone-free status and complication rates after percutaneous nephrolithotomy: a single center study with 437 cases[J]. J Endourol, 2015, 29(9): 1006-1010.
[20]
Vernez S L, Okhunov Z, Motamedinia P, et al. Nephrolithometric scoring systems to predict outcomes of percutaneous nephrolithotomy[J]. Rev Urol, 2016, 18(1): 15-17.
[21]
Vicentini FC, Serzedello FR, Thomas K, et al. What is the quickest scoring system to predict percutaneous nephrolithotomy outcomes? A comparative study among S.T.O.N.E score, Guy's Stone Ccore and CROES nomogram[J]. Int Braz J Urol, 2017, 43(6): 1102-1109.
[22]
彭国辉,李汉忠,李秉诚, 等. SHA.LIN、S.T.O.N.E评分系统和Guy's分级法预测经皮肾镜取石术结石清除率准确性的比较研究[J]. 中华泌尿外科杂, 2016, 37(3): 199-205.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[9] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 曹彬, 王强, 卢扬柏, 黄红星, 黄亚强, 龙永富, 钟睿, 李灿永, 罗刚. 单孔经皮肾镜和腹腔镜处理肾囊肿的术式对比研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 566-571.
[13] 石兵, 张智, 陈金海, 唐文. 基于电磁跟踪和手术导航系统的实时超声引导下两种经皮肾盏穿刺方法的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 572-578.
[14] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要